Therapeutic Oncolytic Monitoring as a Tool for Effective Exposure to 5-FU in Patients With Locally Advanced, Resectable Gastric or Gastro-oesophageal Junction Cancer Treated With Perioperative FLOT
Condition(s):TDM of 5-FU; Pharmacokinetic Observational StudyLast Updated:December 30, 2022Recruiting